Assignee
REGULUS THERAPEUTICS INC
US·47 granted patents·30 pending applications·392 citations·filing 2004–2025
Top patents by PatentIndex Score
77 records- 0199US7683036B2Oligomeric compounds and compositions for use in modulation of small non-coding RNAsREGULUS THERAPEUTICS INC·Filed 2004·Granted Mar 23, 2010·182 cites·40 claims
- 0296US9359609B2Methods for treatment of alport syndromeREGULUS THERAPEUTICS INC·Filed 2015·Granted Jun 7, 2016·26 cites·20 claims
- 0396US7759319B2Oligomeric compounds and compositions for use in modulation of pri-mirnasREGULUS THERAPEUTICS INC·Filed 2006·Granted Jul 20, 2010·33 cites·20 claims
- 0495US9309513B2MicroRNA compounds and methods for modulating miR-122REGULUS THERAPEUTICS INC·Filed 2014·Granted Apr 12, 2016·13 cites·15 claims
- 0594US9506030B2Compounds and methods for enhanced cellular uptakeREGULUS THERAPEUTICS INC·Filed 2014·Granted Nov 29, 2016·18 cites·25 claims
- 0694US8912161B2MicroRNA compounds and methods for modulating miR-21 activityREGULUS THERAPEUTICS INC·Filed 2014·Granted Dec 16, 2014·15 cites·10 claims
- 0793US9574194B2MicroRNA compounds and methods for modulating miR-122REGULUS THERAPEUTICS INC·Filed 2016·Granted Feb 21, 2017·5 cites·34 claims
- 0893US9157083B2MicroRNA compounds and methods for modulating miR-122REGULUS THERAPEUTICS INC·Filed 2014·Granted Oct 13, 2015·9 cites·20 claims
- 0993US8859521B2Oligomeric compounds and compositions for use in modulation of small non-coding RNAsREGULUS THERAPEUTICS INC·Filed 2013·Granted Oct 14, 2014·7 cites·22 claims
- 1092US9267137B2MicroRNA compounds and methods for modulating miR-21 activityREGULUS THERAPEUTICS INC·Filed 2015·Granted Feb 23, 2016·8 cites·21 claims
- 1192US9012423B2Methods for treatment of alport syndromeREGULUS THERAPEUTICS INC·Filed 2013·Granted Apr 21, 2015·13 cites·26 claims
- 1291US9970007B2Targeting microRNAs for the treatment of fibrosisREGULUS THERAPEUTICS INC·Filed 2016·Granted May 15, 2018·6 cites·16 claims
- 1390US9688985B2MicroRNA compounds and methods for modulating miR-21 activityREGULUS THERAPEUTICS INC·Filed 2016·Granted Jun 27, 2017·6 cites·6 claims
- 1490US8969317B2MicroRNA compounds and methods for modulating miR-21 activityREGULUS THERAPEUTICS INC·Filed 2013·Granted Mar 3, 2015·9 cites·15 claims
- 1589US9139832B2Oligomeric compounds and compositions for use in modulation of small non-coding RNAsREGULUS THERAPEUTICS INC·Filed 2014·Granted Sep 22, 2015·4 cites·20 claims
- 1688US9790496B2Microrna compounds and methods for modulating MIR-21 activityREGULUS THERAPEUTICS INC·Filed 2015·Granted Oct 17, 2017·4 cites·15 claims
- 1787US9970011B2Methods for treatment of alport syndromeREGULUS THERAPEUTICS INC·Filed 2017·Granted May 15, 2018·4 cites·11 claims
- 1887US9752146B2Oligomeric compounds and compositions for use in modulation of small non-coding RNAsREGULUS THERAPEUTICS INC·Filed 2016·Granted Sep 5, 2017·2 cites·24 claims
- 1985US10150967B2MicroRNA compounds and methods for modulating miR-122REGULUS THERAPEUTICS INC·Filed 2017·Granted Dec 11, 2018·3 cites·20 claims
- 2084US10941400B2Compounds and methods for enhanced cellular uptakeREGULUS THERAPEUTICS INC·Filed 2019·Granted Mar 9, 2021·1 cites·17 claims
- 2184US9506062B2Targeting microRNAs for the treatment of liver cancerREGULUS THERAPEUTICS INC·Filed 2015·Granted Nov 29, 2016·3 cites·24 claims
- 2284US9181548B2Targeting micrornas for the treatment of fibrosisREGULUS THERAPEUTICS INC·Filed 2014·Granted Nov 10, 2015·3 cites·13 claims
- 2383US9150857B2Targeting microRNAs for the treatment of liver cancerREGULUS THERAPEUTICS INC·Filed 2014·Granted Oct 6, 2015·4 cites·26 claims
- 2483US2024141350A1Methods for treatment of polycystic kidney diseaseREGULUS THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 2582US10301627B2Targeting microRNAs for the treatment of liver cancerREGULUS THERAPEUTICS INC·Filed 2017·Granted May 28, 2019·2 cites·24 claims
- 2682US9688986B2Methods for treatment of alport syndromeREGULUS THERAPEUTICS INC·Filed 2016·Granted Jun 27, 2017·2 cites·10 claims
- 2780US9447413B2Oligomeric compounds and compositions for use in modulation of small non-coding RNAsREGULUS THERAPEUTICS INC·Filed 2015·Granted Sep 20, 2016·1 cites·20 claims
- 2880US9267138B2Oligomeric compounds and compositions for use in modulation of small non-coding RNAsREGULUS THERAPEUTICS INC·Filed 2015·Granted Feb 23, 2016·1 cites·24 claims
- 2978US11168325B2Methods for treatment of polycystic kidney diseaseREGULUS THERAPEUTICS INC·Filed 2020·Granted Nov 9, 2021·1 cites·15 claims
- 3078US9447412B2Oligomeric compounds and compositions for use in modulation of small non-coding RNASREGULUS THERAPEUTICS INC·Filed 2013·Granted Sep 20, 2016·1 cites·14 claims
- 3178US7998677B2MicroRNA detectionREGULUS THERAPEUTICS INC·Filed 2009·Granted Aug 16, 2011·1 cites·16 claims
- 3278US2023109466A1Compositions for treatment of polycystic kidney diseaseREGULUS THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 3377US9970009B2MicroRNA compounds and methods for modulating miR-21 activityREGULUS THERAPEUTICS INC·Filed 2017·Granted May 15, 2018·1 cites·20 claims
- 3477US2026055406A1Methods for treatment of polycystic kidney diseaseREGULUS THERAPEUTICS INC·Filed 2025·Application pending·0 cites
- 3576US10584336B2Oligomeric compounds and compositions for use in modulation of small non-coding RNAsREGULUS THERAPEUTICS INC·Filed 2018·Granted Mar 10, 2020·0 cites·19 claims
- 3676US10240151B2Compounds and methods for enhanced cellular uptakeREGULUS THERAPEUTICS INC·Filed 2016·Granted Mar 26, 2019·1 cites·21 claims
- 3775US10633657B2Methods for treatment of polycystic kidney diseaseREGULUS THERAPEUTICS INC·Filed 2016·Granted Apr 28, 2020·1 cites·20 claims
- 3875US2022213483A1Methods for treatment of polycystic kidney diseaseREGULUS THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 3974US2021108205A1MicroRNA Compounds and Methods for Modulating MIR-122REGULUS THERAPEUTICS INC·Filed 2020·Application pending·0 cites
- 4073US10072265B2Oligomeric compounds and compositions for use in modulation of small non-coding RNAsREGULUS THERAPEUTICS INC·Filed 2017·Granted Sep 11, 2018·0 cites·20 claims
- 4173US2019144864A1MicroRNA Compounds and Methods for Modulating MIR-122REGULUS THERAPEUTICS INC·Filed 2018·Application pending·0 cites
- 4272US10138484B2Targeting microRNAs for metabolic disordersREGULUS THERAPEUTICS INC·Filed 2017·Granted Nov 27, 2018·1 cites·22 claims
- 4372US10093926B2Oligomeric compounds and compositions for use in modulation of small non-coding RNAsREGULUS THERAPEUTICS INC·Filed 2017·Granted Oct 9, 2018·0 cites·20 claims
- 4472US9528108B2Oligomeric compounds and compositions for use in modulation of small non-coding RNASREGULUS THERAPEUTICS INC·Filed 2014·Granted Dec 27, 2016·0 cites·21 claims
- 4572US2015094461A1Oligomeric compounds and compositions for use in modulation of small non-coding rnasREGULUS THERAPEUTICS INC·Filed 2014·Application pending·0 cites
- 4671US2025283082A1Compositions for Treatment of Polycystic Kidney DiseaseREGULUS THERAPEUTICS INC·Filed 2025·Application pending·0 cites
- 4770US2021095282A1Modified Oligonucleotides for Treatment of Polycystic Kidney DiseaseREGULUS THERAPEUTICS INC·Filed 2020·Application pending·0 cites
- 4869US9487783B2Targeting microRNAs for metabolic disordersREGULUS THERAPEUTICS INC·Filed 2015·Granted Nov 8, 2016·1 cites·8 claims
- 4969US2020392501A1Methods for treatment of polycystic kidney diseaseREGULUS THERAPEUTICS INC·Filed 2020·Application pending·0 cites
- 5067US9663787B2Oligomeric compounds and compositions for use in modulation of small non-coding RNAsREGULUS THERAPEUTICS INC·Filed 2015·Granted May 30, 2017·0 cites·21 claims
Showing the top 50 of 77 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when REGULUS THERAPEUTICS INC files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →